These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 14346667)

  • 21. ANTI-MESODERMAL ACTIVITY OF A NITROGEN MUSTARD DERIVATIVE.
    JURAND A
    J Embryol Exp Morphol; 1963 Dec; 11():689-96. PubMed ID: 14081989
    [No Abstract]   [Full Text] [Related]  

  • 22. REGIONAL PERFUSION CHEMOTHERAPY OF ADVANCED CANCER.
    LEONE LA
    R I Med J; 1963 Sep; 46():470-6. PubMed ID: 14048577
    [No Abstract]   [Full Text] [Related]  

  • 23. [Antiblastic chemotherapy: 3 recent chloramine derivatives (cyclophosphamide, nitrogen mustard derivative of uracil, and sarcolysin)].
    GROSSI F
    Clin Ter; 1961 Apr; 20():422-9. PubMed ID: 13709071
    [No Abstract]   [Full Text] [Related]  

  • 24. [NEPHROLOGY IN 1964].
    LAGRUE G; MILLIEZ P
    Rev Prat; 1964 Jun; 14():2271-309. PubMed ID: 14177815
    [No Abstract]   [Full Text] [Related]  

  • 25. TOXICITY OF A NUCLEOTOXIC AGENT, MUSTINE HYDROCHLORIDE, AND ITS ENHANCEMENT BY 5-HYDROXYTRYPTAMINE PRETREATMENT.
    UROIC B; RABADJIJA M; SUPEK Z
    J Pharm Pharmacol; 1964 Jan; 16():61-2. PubMed ID: 14106568
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of nitrogen mustard on the liver, administered by the isolated perfusion technique.
    CHUNG WB; FORWARD AD; BROWN DA
    Surg Forum; 1961; 12():127-8. PubMed ID: 13879408
    [No Abstract]   [Full Text] [Related]  

  • 27. [On changes in the iron level and serum protein fractions after cytostatic therapy with N-oxide mustard gas and a nitrogen mustard phosphamide ester].
    HENNE HF
    Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1961; 297():128-38. PubMed ID: 13713336
    [No Abstract]   [Full Text] [Related]  

  • 28. CLINICAL EVALUATION OF URACIL MUSTARD.
    WILLIAMS HM
    Cancer Chemother Rep; 1963 Oct; 32():73-6. PubMed ID: 14088838
    [No Abstract]   [Full Text] [Related]  

  • 29. EXPERIMENTAL DESTRUCTION OF THE DOG PROSTATE BY INTRAARTERIAL INJECTIONS OF CHEMOTHERAPEUTIC AGENTS.
    MCDONALD DF; MACGILLIS AJ
    Pac Med Surg; 1964; 72():343-6. PubMed ID: 14218723
    [No Abstract]   [Full Text] [Related]  

  • 30. Experiments on the therapeutic index of nitrogen mustard (HN2).
    WHITE LP
    Acta Unio Int Contra Cancrum; 1960; 16():800-6. PubMed ID: 13844375
    [No Abstract]   [Full Text] [Related]  

  • 31. EFFECT OF TESTOSTERONE ENANTHATE AND ALKYLATING AGENTS ON MULTIPLE MYELOMA.
    BRODSKY I; DENNIS LH; DECASTRO NA; BRADY L; KAHN SB
    JAMA; 1965 Sep; 193():874-8. PubMed ID: 14341128
    [No Abstract]   [Full Text] [Related]  

  • 32. THE USE OF HUMAN TUMOR EFFUSIONS IN PRIMARY CULTURE FOR TESTING CHEMOTHERAPEUTIC COMPOUNDS. A PRELIMINARY REPORT.
    DIPAOLO JA
    Cancer; 1964 Mar; 17():391-4. PubMed ID: 14132188
    [No Abstract]   [Full Text] [Related]  

  • 33. An unusual allergic reaction to nitrogen mustard.
    MARQUEZ AH
    Am Pract Dig Treat; 1961 Apr; 12():271-4. PubMed ID: 13767085
    [No Abstract]   [Full Text] [Related]  

  • 34. THE TREATMENT OF CARCINOMA IN DOGS' BLADDERS WITH CYTOTOXIC DRUGS.
    BOYLAND E; KINDER CH; WILLIAMS K
    Invest Urol; 1965 Mar; 2():446-52. PubMed ID: 14261785
    [No Abstract]   [Full Text] [Related]  

  • 35. [Chemotherapy of tumors. I. Mustard gas and nitrogen mustard derivatives; synthetic review].
    PAOLINO W
    Minerva Med; 1953 Jan; 44(1-2):39-51. PubMed ID: 13054389
    [No Abstract]   [Full Text] [Related]  

  • 36. [On the experimental production of phocomeli in the chick embryo using nitrogen mustard].
    SALZGEBER B
    C R Hebd Seances Acad Sci; 1962 May; 254():3591-3. PubMed ID: 14496542
    [No Abstract]   [Full Text] [Related]  

  • 37. [Marrow protection with pentnucleotides during treatment with cytotoxic drugs].
    ANDREU URRA J; RIVERO FONTAN JL
    Hisp Med; 1955 Sep; 12(135):435-8. PubMed ID: 13306135
    [No Abstract]   [Full Text] [Related]  

  • 38. Toxicological and clinical evaluation of a new nitrogen mustard, 2-[di-2(chloroethyl)-aminomethyl]benzimidazole.
    ULTMANN JE; THOMPSON HG; HIRSCHBERG E; ZAIDENWEBER J; GELLHORN A
    Cancer Res; 1959 Aug; 19():719-25. PubMed ID: 13855167
    [No Abstract]   [Full Text] [Related]  

  • 39. [Evaluation of the specificity of anti-proliferative drugs. Comparison of nitrogen mustard, triethylene melamine and cyclophosphamide].
    SCALTRINI GC; TOGNELLA S; CONIGLIARO S; GRIFONI V
    Haematol Lat; 1961; 4():411-22. PubMed ID: 14497771
    [No Abstract]   [Full Text] [Related]  

  • 40. Protection against systemic toxicity due to nitrogen mustard.
    ROSS CA; CAR BERRY DM; KRAUS GE
    Surg Forum; 1960; 11():43-5. PubMed ID: 13743580
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.